ADARx Prices Upsized $446M Nasdaq IPO at $17 on siRNA Pipeline
ADARx Pharmaceuticals upsized its Nasdaq IPO to 26.25M shares at $17.00, raising $446.3M alongside an $89M AbbVie private placement.
ADARx Pharmaceuticals upsized its Nasdaq IPO to 26.25M shares at $17.00, raising $446.3M alongside an $89M AbbVie private placement.
Runway Growth Finance priced $45M of 7.75% Notes due 2031 to redeem its 9% 2027 notes and repay bank debt, extending duration at lower coupon cost.
Sysco closed C$1.5B in Canadian senior notes and executed agreements for $14.65B in USD debt and €1.0B in EUR debt to fund its Jetro Restaurant Depot deal.
Learn how Fed Open Market Operations work, how the New York Fed Desk trades with primary dealers, and how permanent vs. temporary repos steer interest rates.
McGraw Hill announced a $500 million senior secured notes offering and an $830 million Term Loan B to refinance existing credit facilities and 2028 notes.
Learn how SEC Rule 415 and Form S-3 shelf registrations work, from base prospectuses and WKSI rules to shelf takedowns and dilution mechanics.
TTM Technologies completed a $500M offering of 6.750% senior notes due 2034 to fund its $1.1B cash acquisition of Epiq Solutions and corporate needs.
Learn the difference between clean price and dirty price in bond trading, how accrued interest is calculated, day-count conventions, and IRS tax treatment.
Viking Therapeutics priced an upsized $500M capital raise, pairing $275M in common stock at $35 and $225M in 2% convertible senior notes due 2032.
Learn how capped call transactions work in convertible bond offerings, how lower and cap strikes offset equity dilution, and why dealers delta-hedge.